Biotechnology patent disputes. Amgen plays for time.
Gershon
D
D
D004345:Drug Industry / Q000331:legislation & jurisprudence*; D004921:Erythropoietin; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D011994:Recombinant Proteins; D014481:United States
D011994:Recombinant Proteins; D004921:Erythropoietin